HemoGenyx Pharmaceuticals Plc (HOPHF)
2.33
0.00 (0.00%)
USD |
OTCM |
Oct 15, 16:00
HemoGenyx Pharmaceuticals Cash from Operations (TTM) : -1.937M for June 30, 2026
Cash from Operations (TTM) Chart
Historical Cash from Operations (TTM) Data
| Date | Value |
|---|---|
| June 30, 2026 | -1.937M |
| December 31, 2025 | -4.268M |
| June 30, 2025 | -6.921M |
| December 31, 2024 | -5.314M |
| June 30, 2024 | -6.322M |
| December 31, 2023 | -7.477M |
| June 30, 2023 | -6.404M |
| December 31, 2022 | -3.509M |
| Date | Value |
|---|---|
| June 30, 2022 | -3.276M |
| December 31, 2021 | -3.584M |
| June 30, 2021 | -3.143M |
| December 31, 2020 | -2.600M |
| June 30, 2020 | -1.635M |
| December 31, 2019 | -1.516M |
| June 30, 2019 | -1.793M |
| December 31, 2018 | -1.796M |
Cash From Operations Definition
Represents the net cash flow from the company's business operations.
Cash from Operations (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Operations (TTM) Benchmarks
| Silence Therapeutics Plc | -41.79M |
| Biodexa Pharmaceuticals Plc | -9.219M |
| NuCana Plc | -6.332M |
| Mereo BioPharma Group Plc | -25.28M |
| Compass Pathways Plc | -160.76M |